Skip to main content
. 2020 Jul 8;10:11236. doi: 10.1038/s41598-020-67908-4

Figure 5.

Figure 5

Let-7c targets affect response to Osimertinib and in vivo effects of let-7c. (A) H1975 cells or (B) HCC827-T790M cells were silenced for WNT1 or TCF-4, using specific siRNAs, and then treated with various indicated doses of Osimertinib for 72 h. Thereafter, proliferation of cells was tested by XTT assay. (C) H1975 cells or (D) HCC827-T790M cells (control or transfected with either pre- or anti-let-7c) were implanted in SCID mice (n = 10 pergroup) for in vivo xenograft study and the tumor volume was calculated, as described in the Methods. Levels of let-7c targets, wnt1 (E) and TCF-4 (F) were evaluated in the tumors from control vs pre-let-7c groups of H1975 xenografts. **p < 0.01, relative to control.